Replimune informed the state of upcoming layoffs. The company will cut 63 jobs. This action follows an FDA decision. The Food and Dr-g Administration rejected its melanoma treatment. This was the second rejection for the dr-g.
https://www.bizjournals.com/boston/news/2026/04/15/replimune-layoffs-dr-g-rejection.html